RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.
International research confirms: lockdowns have negative impact on many young people Lockdowns have a negative impact on the physical and mental health of many young people. They get less exercise and experience more feelings of depression, loneliness and insecurity.
Quality of protective equipment insufficient during COVID-19 crisis The personal protective equipment (PPE) purchased at the national level during the COVID-19 crisis for use in the healthcare sector only partly met the required standards of quality.
Nearly a quarter-million positive COVID-19 tests last week Last week*, 242,961 positive COVID-19 tests were reported to RIVM**. That is an increase of 21% compared to the week before that.
200 thousand people tested positive in one week 201,536 positive COVID-19 tests were reported to RIVM last week. That is an increase of 77% compared to the previous week. Such high numbers of reported infections within just one week have never been seen before in the Netherlands.
Omicron causes 35% increase in positive COVID-19 tests, despite lockdown In the past week*, the number of reported positive COVID-19 tests increased by 35% compared to the week before that. The number of people tested by the GGD was about the same.
A pregnant woman can protect her baby against whooping cough with 22-week vaccination From 16 December 2019, pregnant women in the Netherlands will be offered the 22-week vaccination. With this vaccination, a pregnant woman protects her child and herself against whooping cough.
Report on the developments of the National Immunisation Programme: stabilisation of participation and low level of disease In the first six months of 2019, the number of notified meningococcal serogroup W (MenW) disease cases decreased in almost all age groups, after a continuous increase since 2015.
Vaccination against meningococcal disease starts for teens aged 14 to 18 This spring, about 860,000 young people in the Netherlands will receive an invitation for a vaccination against meningococcal disease.